×
For best experience we recommend to activate Javascript in your browser.
MARK3 antibody (AA 435-658)
The Mouse Monoclonal anti-MARK3 antibody has been validated for WB, ELISA, IHC and FACS. It is suitable to detect MARK3 in samples from Human and Mouse.
Quick Overview for MARK3 antibody (AA 435-658) (ABIN1845731)
Target
See all MARK3 Antibodies
MARK3
(MAP/microtubule Affinity-Regulating Kinase 3 (MARK3))
Reactivity
All reactivities for MARK3 antibodies
Human, Mouse
Host
All hosts for MARK3 antibodies
Mouse
Clonality
All clonalities for MARK3 antibodies
Monoclonal
Conjugate
All conjugates for MARK3 antibodies
This MARK3 antibody is un-conjugated
Application
All applications for MARK3 antibodies
Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Flow Cytometry (FACS)
Product Details anti-MARK3 Antibody
(hide)
Binding Specificity
All epitopes for MARK3 antibodies
AA 435-658
Purification
Purified antibody
Immunogen
Purified recombinant fragment of human MARK3 (AA: 435-658) expressed in E. Coli.
Isotype
IgG1
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
1.0 mg/mL
Buffer
PBS with 0.05 % sodium azide and 0.5 % protein stabilizer.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
-20 °C
Storage Comment
Aliquot and store at -20 °C. Avoid repeated freeze/thaw cycles.
Target Details for MARK3
(hide)
Target
MARK3
(MAP/microtubule Affinity-Regulating Kinase 3 (MARK3))
Alternative Name
MARK3
Background
The protein encoded by this gene is activated by phosphorylation and in turn is involved in the phosphorylation of tau proteins MAP2 and MAP4. Several transcript variants encoding different isoforms have been found for this gene.
Molecular Weight
87 kDa
Gene ID
4140
UniProt
P27448
Pathways
SARS-CoV-2 Protein Interactome
Recently viewed
(hide)
Chat with us , powered by LiveChat